Federal Register Notice: FDA is making available a draft guidance for industry entitled Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format. This guidance is one of a series intended to help applicants in drafting prescription drug labeling in which prescribing information is clear and accessible and complying with the new requirements in the final rule on the content and format of labeling for prescription drug and biological products. To download this guidance, click here. To view this notice, click here.